D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.61% |
| 2 | Healthcare | 10.26% |
| 3 | Consumer Discretionary | 10.07% |
| 4 | Financials | 8.17% |
| 5 | Communication Services | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INSY
2351
DELISTED
Insys Therapeutics, Inc.
INSY
| $1.2M | ﹤0.01% |
134,714
+4,189
| +3% | +$43.2K |
|
2352
Invitation Homes
INVH
$17.7B
| $1.2M | ﹤0.01% |
52,774
-24,776
| -32% | -$549K |
|
2353
CALL
State Street
STT
$50.9B
| $1.19M | ﹤0.01% |
12,500
| – | – |
|
|
BMTC
2354
DELISTED
Bryn Mawr Bank Corp
BMTC
| $1.19M | ﹤0.01% |
27,140
-2,881
| -10% | -$120K |
|
|
SMPLW
2355
DELISTED
The Simply Good Foods Company Warrant
SMPLW
| $1.19M | ﹤0.01% |
+500,000
| New | +$1.22M |
|
2356
FedEx
FDX
$74.5B
| $1.19M | ﹤0.01% |
5,260
-223,857
| -98% | -$47.7M |
|
|
ASCMA
2357
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $1.19M | ﹤0.01% |
91,057
-159
| -0.2% | -$2.11K |
|
2358
Century Communities
CCS
$2B
| $1.18M | ﹤0.01% |
47,931
-7,152
| -13% | -$173K |
|
2359
Boise Cascade
BCC
$2.74B
| $1.18M | ﹤0.01% |
33,838
-7,899
| -19% | -$240K |
|
2360
Federal Realty Investment Trust
FRT
$10.9B
| $1.18M | ﹤0.01% |
9,510
-12,621
| -57% | -$1.62M |
|
2361
Sibanye-Stillwater
SBSW
$5.92B
| $1.18M | ﹤0.01% |
280,885
+255,268
| +996% | +$1.28M |
|
2362
Grupo Aval
AVAL
$5.67B
| $1.18M | ﹤0.01% |
131,566
+22,219
| +20% | +$196K |
|
2363
CALL
Alnylam Pharmaceuticals
ALNY
$36.3B
| $1.18M | ﹤0.01% |
10,000
| – | – |
|
2364
PUT
Markel Group
MKL
$25B
| $1.18M | ﹤0.01% |
1,100
| – | – |
|
|
FCE.A
2365
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $1.17M | ﹤0.01% |
45,994
-18,922
| -29% | -$463K |
|
|
CLR
2366
PUT
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $1.17M | ﹤0.01% |
30,300
| – | – |
|
|
AT
2367
DELISTED
Atlantic Power Corporation
AT
| $1.17M | ﹤0.01% |
477,091
+8,756
| +2% | +$21K |
|
|
BHR
2368
Braemar Hotels & Resorts
BHR
$153M
| $1.17M | ﹤0.01% |
124,156
-82,369
| -40% | -$808K |
|
2369
PennantPark Floating Rate Capital
PFLT
$681M
| $1.17M | ﹤0.01% |
80,677
+57,829
| +253% | +$824K |
|
2370
PUT
Incyte
INCY
$23.5B
| $1.17M | ﹤0.01% |
10,000
| – | – |
|
|
ICD
2371
DELISTED
Independence Contract Drilling, Inc.
ICD
| $1.17M | ﹤0.01% |
15,346
-310
| -2% | -$21.9K |
|
2372
Geospace Technologies
GEOS
$91.6M
| $1.16M | ﹤0.01% |
65,310
-4,626
| -7% | -$70.4K |
|
2373
McGrath RentCorp
MGRC
$2.94B
| $1.16M | ﹤0.01% |
26,555
-32,210
| -55% | -$1.23M |
|
2374
Vornado Realty Trust
VNO
$7.47B
| $1.15M | ﹤0.01% |
15,013
-525,537
| -97% | -$40.1M |
|
2375
National CineMedia
NCMI
$354M
| $1.15M | ﹤0.01% |
16,477
+10,410
| +172% | +$673K |
|
Similar funds
D.E. Shaw & Co's Q3 2017 Portfolio in Review
As of Q3 2017, D.E. Shaw & Co held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
D.E. Shaw & Co's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- D.E. Shaw & Co's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- D.E. Shaw & Co added most to Comcast in Q3 2017, an estimated $354M increase.
- D.E. Shaw & Co's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- D.E. Shaw & Co fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- D.E. Shaw & Co's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- D.E. Shaw & Co opened 469 new positions and closed 370 in Q3 2017.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.